NO-Synthase Activity in Patients with Coronary Heart Disease Associated with Hypertension of Different Age Groups

Anna Besedina1

  • 1Department of Family Medicine, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.

Insights

Coronary heart disease (CHD) patients show reduced nitric oxide (NO) production from endothelial nitric oxide synthase (eNOS) and increased NO from inducible nitric oxide synthase (iNOS), especially in older individuals and those with hypertension.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Medical Science

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Hypertension is a significant independent risk factor for CHD development.
  • Dysfunctional nitric oxide (NO) generation is implicated in CHD pathogenesis.

Purpose of the Study:

  • To investigate the activity of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) in patients with isolated CHD.
  • To compare NOS activity in patients with CHD associated with hypertension (HT) across different age groups.

Main Methods:

  • Enrolled 50 patients with isolated CHD and 42 with CHD and HT.
  • Quantified nitric oxide synthase (NOS) activity by measuring nitrite anion formation.

Main Results:

  • Elderly donors exhibited significantly increased iNOS activity.
  • Patients with isolated CHD showed significantly reduced cNOS activity compared to controls.
  • cNOS activity reduction was more pronounced in elderly CHD patients.
  • eNOS activity alterations were more significant in CHD patients with hypertension.
  • cNOS inhibition correlated with a sharp increase in iNOS activity.

Conclusions:

  • Endothelial dysfunction in CHD with HT involves reduced NO synthesis by cNOS and increased systemic NO from iNOS.
  • The deficit in endothelial NO and excess "harmful" NO from iNOS are exacerbated in elderly patients.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...